Colitis-related rat colon carcinogenesis induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate (review)

Oncology Reports

Volumn 7, Issue 3, 2000, Pages 501-508

  Tanaka, Takuji ^a   Kohno, Hiroyuki ^a   Murakami, Manabu ^a   Shimada, Reona ^a   Kagami, Seiko ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

1 hydroxyanthraquonone; Cell proliferation; Colitis associated colon cancer; Cyclooxygenase; Cytokines; Gene mutation; Methylazoxymethanol acetate; Rats

Indexed keywords

1,4 DIMETHOXY 2 HYDROXYANTHRAQUINONE; 1,4-DIMETHOXY-2-HYDROXYANTHRAQUINONE; ANTHRAQUINONE DERIVATIVE; CARCINOGEN; METHYLAZOXYMETHANOL ACETATE;

ANIMAL; CHEMICALLY INDUCED DISORDER; COLON; COLON TUMOR; DRUG EFFECT; HUMAN; INTESTINE MUCOSA; PATHOLOGY; RAT; REVIEW; ULCERATIVE COLITIS;

ANIMALS; ANTHRAQUINONES; CARCINOGENS; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; HUMANS; INTESTINAL MUCOSA; METHYLAZOXYMETHANOL ACETATE; RATS;

EID: 0034186629     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.3.501     Document Type: Review

References (32)

1. Ames BN: Identifying environmental chemicals causing mutation and cancer. Science 204: 587-593, 1979.
2. Blomeke B, Pogisnky B, Schmutte C, Marquardt H and Westendorf J: Formation of genotoxic metabolites from anthraquinone glycosides, present in Rubia tinctorum L. Mutat Res 265: 263-272, 1992.
3. Mori H, Sugie S, Ohbayashi F, Kuniyasu T, Yamazaki M, Hamasaki T and Williams GM: Genotoxicity of a variety of mycotoxins in the hepatocyte primary culture/DNA repair test using rat and mouse hepatocytes. Cancer Res 44: 2918-2923, 1984.
4. Kawai K, Mori H, Sugie S, Yoshimi N, Inoue T, Nakamura T, Nozawa Y and Matsushima T: Genotoxicity in the hepatocyte/ DNA repair test and toxicity to liver mitochondria of 1-hydroxyanthraquinone and several dihydroxyanthraquinones. Cell Biol Toxicol 2: 457-467, 1986.
5. Mori H, Sugie S, Niwa K, Yoshimi N, Tanaka T and Hirono I: Carcinogenicity of chrysazin in large intestine and liver of mice. Jpn J Cancer Res 77: 871-876, 1986.
6. Mori H, Sugie S, Niwa K, Takahashi M and Kawai K: Induction of intestinal tumours in rats by chrysazin. Br J Cancer 52: 781-783, 1986.
7. Mori H, Yoshimi N, Iwata H, Mori Y, Hara A, Tanaka T and Kawai K: Carcinogenicity of naturally occurring 1-hydroxyanthraquinone in rats: induction of large bowel, liver and stomach neoplasms. Carcinogenesis 11: 799-802, 1990.
8. Mori Y, Yoshimi N, Iwata H, Tanaka T and Mori H: The synergistic effect of 1-hydroxyanthraquinone on methylazoxymethanol acetate-induced carcinogenesis in rats. Carcinogenesis 12: 335-338, 1991.
9. Tanaka T, Suzui M, Kojima T, Okamoto K, Wang A and Mori H: Chemoprevention of the naturally occurring carcinogen, 1-hydroxyanthraquinone-induced carcinogenesis by the non-steroidal anti-inflammatory drug indomethacin in rats. Cancer Detect Prev 19: 418-425, 1995.
10. Hilgert I, Cudlin J, Steinerova N and Vanek Z: Antitumour and immunosuppressive activity of hydroxyanthraquinones and their glucosides. Folia Biol 23: 99-109, 1977.
11. Kern SE, Redston M, Seymour AB, Caldas C, Powell SM, Kornacki S and Kinzler KW: Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 107: 420-428, 1994.
12. Greenwald BD, Harpaz N, Yin J, Huang Y, Tong Y, Brown VL, McDaniel T, Newkirk C, Resau JH and Meltzer SJ: Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumors suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 52: 741-745, 1992.
13. Lashner BA, Kane SV and Hanauer SB: Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 85: 1083-1087, 1990.
14. Pascal RR: Dysplasia and early carcinoma in inflammatory bowel disease and colorectal carcinomas. Hum Pathol 25: 1160-1171, 1994.
15. Dieleman LA, Pena AS, Meuwissen SGM and van Rees EP: Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol 223 (Suppl 32): 99-104, 1997.
16. Whiteley LO, Hudson LJ and Pretlow TP: Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and non-genotoxic colon carcinogen. Toxicol Pathol 24: 681-689, 1996.
17. Mori H, Mori Y, Tanaka T, Yoshimi N, Sugie S, Kawamori T and Narisawa T: Cell kinetic analysis of the mucosal epithelium and assay of ornithine decarboxylase activity during the process of 1-hydroxyanthraquinone-induced large bowel carcinogenesis in rats. Carcinogenesis 13: 2217-2220, 1992.
18. 2 and cyclooxygenase, in the large bowel mucosa and neoplasms of F344 rats treated with naturally occurring carcinogen, 1-hydroxyanthraquinone. Cancer Lett 97: 75-82, 1995.
19. Tanaka T, Kojima T, Yoshimi N, Sugie S and Mori H: Inhibitory effect of the non-steroidal anti-inflammatory drug, indomethacin on the naturally occurring carcinogen, 1-hydroxyanthraquinone in male ACI/N rats. Carcinogenesis 12: 1949-1952, 1991.
20. Old LJ: Tumor necrosis factor (TNF). Science 230: 630-632, 1985.
21. Lazutka JR and Rudaitiene S: Effects of tumor necrosis factor on cell proliferation kinetics and sister chromatid exchange frequency in human lymphocytes. Carcinogenesis 12: 1355-1357, 1991.
22. Komori A, Yatsunami J, Suganuma M, Okabe S, Abe S, Sakai A, Sasaki K and Fujiki H: Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res 53: 1982-1985, 1993.
23. Guy GR, Cao X, Chua SP and Tan YH: Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J Biol Chem 267: 1846-1852, 1992.
24. Lee WY, Fischer SM, Butler AP and Locniskar MF: Modulation of interleukin-1α mRNA expression in mouse epidermis by tumor promoters and antagonists. Mol Carcinogenesis 7: 26-35, 1993.
25. Yoshimi N, Sato S, Makita H, Wang A, Hirose Y, Tanaka T and Mori H: Expression of cytokines, TNF-α and IL-1α, in MAM acetate and 1-hydroxyanthraquinone-induced colon carcinogenesis in rats. Carcinogenesis 15: 783-785, 1994.
26. Suzui M, Yoshimi N, Ushijima T, Hirose Y, Makita H, Wang A, Kawamori T, Tanaka T, Mori H and Nagao M: No involvement of Ki-ras or p53 gene mutations in colitis-associated rat colon tumors induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate. Mol Carcinogenesis 12: 193-197, 1995.
27. Suzui M, Ushijima T, Yoshimi N, Nakagama H, Hara A, Sugimura T, Nagao M and Mori H: No involvement of APC gene mutation in ulcerative colitis-associated rat colon carcinogenesis induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate. Mol Carcinogenesis 20: 389-393, 1997.
28. Levin B: Ulcerative colitis and colon cancer: biology and surveillance. J Cell Biochem 16G: 47-50, 1992.
29. Kakiuchi H, Watanabe M, Ushijima T, Toyota M, Imai K, Weisburger JH, Sugimura T and Nagao M: Specific 5′-GGGA-3′-5′→GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc Natl Acad Sci USA 92: 910-914, 1995.
30. Dashwood RH, Suzui M, Nakagama H, Sugimura T and Nagao M: High frequency of β-catenin (Ctnnbl) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res 58: 1127-1129, 1998.
31. Takahashi M, Fukuda K, Sugimura T and Wakabayashi K: β-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 58: 42-46, 1998.
32. Suzui M, Ushijima T, Dashwood RH, Yoshimi N, Sugimura T, Mori H and Nagao M: Frequent mutations of the rat β-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone. Mol Carcinogenesis 24: 232-237, 1999.